These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 18852676)

  • 1. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones.
    Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group
    J Bone Joint Surg Am; 2007 Oct; 89(10):2113-23. PubMed ID: 17908885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.
    Geirnaerdt MJ; Hermans J; Bloem JL; Kroon HM; Pope TL; Taminiau AH; Hogendoorn PC
    AJR Am J Roentgenol; 1997 Oct; 169(4):1097-104. PubMed ID: 9308471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological investigation for comparison of cartilaginous tumors of unknown biological course with unequivocal chondrosarcomas.
    Féaux de Lacroix W; Dietlein M; Schmidt J; Stützer H
    Zentralbl Pathol; 1992 Nov; 138(5):339-43. PubMed ID: 1477083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients.
    De Beuckeleer LH; De Schepper AM; Ramon F; Somville J
    Eur J Radiol; 1995 Nov; 21(1):34-40. PubMed ID: 8654456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases.
    Mirra JM; Gold R; Downs J; Eckardt JJ
    Clin Orthop Relat Res; 1985 Dec; (201):214-37. PubMed ID: 4064409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating clinical and radiographic features of enchondroma and secondary chondrosarcoma in the foot.
    Gajewski DA; Burnette JB; Murphey MD; Temple HT
    Foot Ankle Int; 2006 Apr; 27(4):240-4. PubMed ID: 16624212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
    Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign cartilaginous tumors].
    Erlemann R
    Radiologe; 2001 Jul; 41(7):548-59. PubMed ID: 11490775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative diagnosis and histopathologic grading of chondrosarcoma].
    Li JP
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):391-3. PubMed ID: 8174490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
    Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
    Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
    Welkerling H; Werner M; Delling G
    Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR differentiation of low-grade chondrosarcoma from enchondroma.
    Choi BB; Jee WH; Sunwoo HJ; Cho JH; Kim JY; Chun KA; Hong SJ; Chung HW; Sung MS; Lee YS; Chung YG
    Clin Imaging; 2013; 37(3):542-7. PubMed ID: 23041161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
    Amling M; Pösl M; Hentz MW; Priemel M; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.